Huan Li1,2, Xiao-Hong Zhu1, Wei Zhu1, Byeong-Yeul Lee1, Hannes Michel Wiesner1, Yi Zhang1, Tao Wang1, and Wei Chen1
1Center for Magnetic Resonance Research,Department of Radiology, University of Minnesota, Minneapolis, MN, United States, Minneapolis, MN, United States, 2Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China
Synopsis
Assessment of myocardial energy metabolism
is crucial for understanding heart function and viable myocardium after myocardial
infarction. Based on our recently developed in vivo Deuterium (2H)
MR spectroscopic (DMRS) approach, we further exploited the DMRS and imaging
(DMRSI) methods for dynamic measurement of the myocardial energy metabolism in
rat heart at 16.4 T. This work demonstrates the feasibility of in vivo DMRS for
assessing myocardial energy metabolisms, and its potential to directly image the
viable myocardium in hearts under conditions such as myocardial infarction.
Introduction
Assessment of energy metabolism is crucial
for understanding myocardial activity and function under physiopathological
conditions. Myocardium mainly obtained energy via aerobic oxidation of various energy substrates including fatty
acids (>60%) and glucose. MR perfusion imaging and SPECT
perfusion imaging are commonly used to assess blood supply of the myocardium, myocardial
ischemia and viability of the myocardium (1). However, these methods are unable
to evaluate the myocardial cellular activity and metabolism directly. Recently,
we developed a novel Deuterium (2H) MR (DMR) spectroscopic (DMRS) approach
for assessing energy metabolisms in preclinical rat brain at ultrahigh field (2). This new method is advantageous
since it eliminates the radioactive tracer commonly employed in SPECT imaging of
myocardial metabolism; and it allows more signal averaging to gain sensitivity
per unit time owing to shorter T1 of deuterated metabolites with
quadrupolar relaxation mechanism. In this study, we aimed to develop and utilize
the dynamic DMRS method for assessing myocardial energy metabolisms in the rat heart
at 16.4 T. Method
Three Sprague Dawley rats (BW=432±34 g) were
anesthetized by 2% isoflurane, and their femoral arteries and veins were
catheterized for blood sampling, physiological monitoring and deuterated
glucose and/or acetate infusion. Rectal temperature was maintained at 37±1℃ using heated circulating water. The animal study protocol was approved by the Institutional Animal
Care and Use Committee of University of Minnesota, and were compliance with the
ARRIVE guidelines. All MR experiments were conducted at 16.4 T/26 cm bore scanner
(Varian/VNMRJ) using a small (~1.2cm diameter) 2H surface coil for deuterium
data acquisition and a large (~3.5cm diameter) 1H surface coil for anatomical
imaging. The 2H coil was inserted into the rat chest via thoracotomy
and placed between the chest wall and the heart with the animal in prone
position. The 1H surface coil was placed at the left side of the
chest at the same level of the heart (see Figure 1). A single-pulse-acquire
sequence was applied to obtain dynamic DMR spectra with 30 s temporal
resolution for 60 min. For each rat, 2 min baseline spectra were acquired
followed by 5 min i.v. infusion of deuterated D-Glucose-6,6-d (d66, Cambridge
Isotope Laboratories, Inc., 1.0 g/kg BW) or deuterated sodium acetate-d3
(Sigma Aldrich, 1.0 g/kg BW) dissolved in 2.5 mL saline. The 2H 3D-CSI
data of rat hearts were also acquired before and after injection of glucose and/or
acetate with 124 mL nominal spatial resolution in approximately 5 min
(spectral width=3 kHz; TR = 45 ms; FOV=4*4*4 cm3, 9*9*5 phase encodes, 15 averages). All resonance signals (deuterated water, glucose (Glc), glutamate/glutamine
(Glx), acetate) were fitted using a MATLAB based program (2). Result
We were able to successfully place the
2H surface coil underneath the heart and reduce the heart motion caused
by breathing during the experiment; the position of the heart and coils were
illustrated in Figure 1; it also displays DMRS imaging of natural abundance
Deuterium-labeled water with excellent sensitivity and spectral quality in rat
heart in vivo. Figure 2 shows representative
DMR spectra of rat hearts (black and red traces represent original and fitted
spectra) under 4 min post-infusion of deuteriated-acetate (a) and 10 min post-infusion
of deuteriated-glucose (b). Model-decomposed individual components of deuterated
water, acetate, glucose and Glx could be characterized clearly. Figure 3a displays
the time courses of deuterated glucose, Glx and water signals before, during
and after infusion of d66 based on the model fitting of the in vivo 2H spectra as shown
in Figure 2a. Figure 3b showed the time courses of deuterated water with
glucose and acetate infusion, respectively. Significantly higher production of
the deuterated water was observed with acetate infusion as compared to the
glucose infusion. Discussion & Conclusion
Myocardium mainly produces ATP energy via aerobic oxidation of various substrates
including fatty acids and glucose with preference on fatty acids. The observed higher
deuteriated-water production under acetate infusion in the heart could be due
to the higher concentration of 2H in acetate infusion than that of glucose;
1g /kg BW of acetate and glucose was used for this study, the concentration of 2H
in acetate is about 3.2 times higher than that of glucose. This work
demonstrates the feasibility and sensitivity of the in vivo DMR imaging
technique for assessing myocardial energy metabolisms, which makes it possible
to image the energy metabolism and assess cardiomyocyte activity in hearts
under normal and diseased states (such as myocardial ischemia&myocardial infarction) at high/ultrahigh field. Further studies and quantification
modeling are needed to find more characteristics of cardiac energy metabolism.Acknowledgements
NIH Grants: R01 NS057560, NS070839,
MH111447, R24 MH106049, U01EB026978, P41 EB015894, P30 NS076408, S10 RR025031.References
(1)
Richard A.P. Takx, et al. (2015)
Circ Cardiovasc Imaging. 8(1), e002666
(2)
Lu, M. et al. (2017) J Creb
Blood Flow Metab.17(11), 3518-3530